Citation Impact
Citing Papers
De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination
2003 StandoutNobel
AID Enzyme-Induced Hypermutation in an Actively Transcribed Gene in Fibroblasts
2002 StandoutScienceNobel
Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
1993
Base-modification mRNA editing through deamination — the good, the bad and the unregulated
1996
Linking class-switch recombination with somatic hypermutation
2001 StandoutNobel
Oncogenic kinase signalling
2001 StandoutNature
The AID enzyme induces class switch recombination in fibroblasts
2002 StandoutNatureNobel
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway
2000 StandoutNobel
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Upstream and downstream of mTOR
2004 Standout
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
2002 StandoutNature
RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia
2000
Determinants for Membrane Association of the Hepatitis C Virus RNA-dependent RNA Polymerase
2001 StandoutNobel
Editing of α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor GluR-B Pre-mRNA in Vitro Reveals Site-selective Adenosine to Inosine Conversion
1995
Editing of glutamate receptor subunit B pre-mRNA in vitro by site-specific deamination of adenosine
1995 StandoutNatureNobel
Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons
2012 Standout
Accurate identification of A-to-I RNA editing in human by transcriptome sequencing
2011
Multifactorial analysis of p53 alteration in human cancer: A review
1994
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Vascular Signaling in Allogenic Solid Organ Transplantation – The Role of Endothelial Cells
2020
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
APOBEC3A Is Implicated in a Novel Class of G-to-A mRNA Editing in WT1 Transcripts
2015
Hyperediting of Multiple Cytidines of Apolipoprotein B mRNA by APOBEC-1 Requires Auxiliary Protein(s) but Not a Mooring Sequence Motif
1996 StandoutNobel
Ekiden to iPS Cells
2009 StandoutNobel
A place in the world for RNA editing
1995
Inhibition of Phosphatidylinositol 3-Kinase Activity by Adenovirus-mediated Gene Transfer and Its Effect on Insulin Action
1998
Intestinal IgA synthesis: regulation of front-line body defences
2003 StandoutNobel
AID mutant analyses indicate requirement for class-switch-specific cofactors
2003 StandoutNobel
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
1993 Standout
3,3′-Diindolylmethane (DIM) induces a G1 cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21WAF1/CIP1 expression
2002
The Emerging p53 Gene Family
1999 StandoutNobel
p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
1995
C to U editing and modifications during the maturation of the mitochondrial tRNAASPin marsupials
1995 StandoutNobel
Alternative mRNA Splicing and Differential Promoter Utilization Determine Tissue-specific Expression of the Apolipoprotein B mRNA-editing Protein (Apobec1) Gene in Mice.
1995
Psoriasis Upregulated Phorbolin-1 Shares Structural but not Functional Similarity to the mRNA-Editing Protein Apobec-1
1999
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
2010 StandoutNature
Nascent-Seq Indicates Widespread Cotranscriptional RNA Editing in Drosophila
2012 StandoutNobel
Compromised HOXA5 function can limit p53 expression in human breast tumours
2000 Nature
Specific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells
1999 StandoutNobel
Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme
2000 StandoutNobel
AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switching
2001 StandoutNatureNobel
Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing.
1994
Accumulation of the FACT complex, as well as histone H3.3, serves as a target marker for somatic hypermutation
2013 StandoutNobel
Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells.
1993
A hallmark of active class switch recombination: Transcripts directed by I promoters on looped-out circular DNAs
2001 StandoutNobel
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
Tissue-specific, developmental and nutritional regulation of the gene encoding the catalytic subunit of the rat apolipoprotein B mRNA editing enzyme: functional role in the modulation of apoB mRNA editing.
1995
Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals.
1995 StandoutNobel
Subcellular Localization, Stability, and trans -Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell Lines
2000 StandoutNobel
Intron sequence directs RNA editing of the glutamate receptor subunit GluR2 coding sequence.
1994
Molecular Mechanism of Class Switch Recombination: Linkage with Somatic Hypermutation
2002 StandoutNobel
Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence
2003 Standout
Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
1997
RNA editing in kinetoplastid protozoa
1997
The C-terminal region of activation-induced cytidine deaminase is responsible for a recombination function other than DNA cleavage in class switch recombination
2009 StandoutNobel
A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme.
1997 StandoutNobel
Biosynthesis of Apolipoprotein B48-containing Lipoproteins
1996 StandoutNobel
WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis.
1995
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins
1998 StandoutNobel
Constitutive Expression of AID Leads to Tumorigenesis
2003 StandoutNobel
Telomerase in kinetoplastid parasitic protozoa
1999 StandoutNobel
Viral Oncoproteins Discriminate between p53 and the p53 Homolog p73
1998 StandoutNobel
Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells.
1995
Histone chaperone Spt6 is required for class switch recombination but not somatic hypermutation
2011 StandoutNobel
Quantitative Regulation of Class Switch Recombination by Switch Region Transcription
2001 StandoutNobel
Variable deletion and duplication at recombination junction ends: Implication for staggered double-strand cleavage in class-switch recombination
2001 StandoutNobel
Activation-induced Deaminase (AID)-directed Hypermutation in the Immunoglobulin Sμ Region
2002 StandoutNobel
Purification and characterization of a human RNA adenosine deaminase for glutamate receptor B pre-mRNA editing
1997 StandoutNobel
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005 StandoutNobel
Functional requirements of AID’s higher order structures and their interaction with RNA-binding proteins
2016 StandoutNobel
RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells
2003 StandoutNobel
Works of Mackenzie Bowman being referenced
Von Willebrand factor regulates complement on endothelial cells
2016
Mutations in p53 as potential molecular markers for human breast cancer.
1991
A rodent model for Wilms tumors: embryonal kidney neoplasms induced by N-nitroso-N'-methylurea.
1994
Molecular cloning of rat Wilms' tumor complementary DNA and a study of messenger RNA expression in the urogenital system and the brain.
1992
RNA editing in the Wilms' tumor susceptibility gene, WT1.
1994